{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:12:56Z","timestamp":1793160776067,"version":"4.5.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["AACSF-22-970586"],"award-info":[{"award-number":["AACSF-22-970586"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U01AG057562"],"award-info":[{"award-number":["U01AG057562"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["K99AG081390"],"award-info":[{"award-number":["K99AG081390"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017644","name":"Sinai Medical Staff Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017644","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.nbd.2025.107012","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T19:23:03Z","timestamp":1750879383000},"page":"107012","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Interneuron transcriptomics reveals pathologic markers of Alzheimer's disease progression"],"prefix":"10.1016","volume":"213","author":[{"given":"Kevin S.","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed H.","family":"Noureldein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana M.","family":"Rigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle J.","family":"Loi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junguk","family":"Hur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masha G.","family":"Savelieff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva L.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2025.107012_bb0005","series-title":"NanoStringNCTools: NanoString nCounter Tools, R package version 1.6.1","author":"Aboyoun","year":"2023"},{"key":"10.1016\/j.nbd.2025.107012_bb0010","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41419-022-05153-5","article-title":"ER stress and UPR in Alzheimer's disease: mechanisms, pathogenesis, treatments","volume":"13","author":"Ajoolabady","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.nbd.2025.107012_bb0015","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.3233\/JAD-181190","article-title":"Parvalbumin-positive neuron loss and amyloid-\u03b2 deposits in the frontal cortex of Alzheimer's disease-related mice","volume":"72","author":"Ali","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2025.107012_bb0020","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1046\/j.1471-4159.2003.02054.x","article-title":"Identification of tau and MAP2 as novel substrates of rho-kinase and myosin phosphatase","volume":"87","author":"Amano","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2025.107012_bb0025","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S1474-4422(18)30490-3","article-title":"The role of astroglia in Alzheimer\u2019s disease: pathophysiology and clinical implications","volume":"18","author":"Arranz","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2025.107012_bb0030","doi-asserted-by":"crossref","first-page":"5557","DOI":"10.1038\/s41380-021-01257-0","article-title":"Impaired spike-gamma coupling of area CA3 fast-spiking interneurons as the earliest functional impairment in the app(NL-G-F) mouse model of Alzheimer\u2019s disease","volume":"26","author":"Arroyo-Garcia","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.nbd.2025.107012_bb0035","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s40520-019-01360-x","article-title":"Alternative splicing in Alzheimer's disease","volume":"33","author":"Biamonti","year":"2021","journal-title":"Aging Clin. Exp. Res."},{"key":"10.1016\/j.nbd.2025.107012_bb0040","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrn3887","article-title":"Spreading of pathology in neurodegenerative diseases: a focus on human studies","volume":"16","author":"Brettschneider","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2025.107012_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/cells10040882","article-title":"Brain CHID1 expression correlates with NRGN and CALB1 in healthy subjects and AD patients","volume":"10","author":"Castrogiovanni","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.nbd.2025.107012_bb0050","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.cell.2020.06.038","article-title":"Spatial transcriptomics and in situ sequencing to study Alzheimer\u2019s disease","volume":"182","author":"Chen","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2025.107012_bb0055","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.neurobiolaging.2013.11.021","article-title":"Role of synaptic activity in the regulation of amyloid beta levels in Alzheimer\u2019s disease","volume":"35","author":"Cheng","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2025.107012_bb0060","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12801","article-title":"The emerging roles of protein homeostasis-governing pathways in Alzheimer's disease","volume":"17","author":"Cheng","year":"2018","journal-title":"Aging Cell"},{"key":"10.1016\/j.nbd.2025.107012_bb0065","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.neuron.2005.10.028","article-title":"Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo","volume":"48","author":"Cirrito","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2025.107012_bb0070","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.neuron.2018.07.039","article-title":"Tau protein disrupts nucleocytoplasmic transport in Alzheimer's disease","volume":"99","author":"Eftekharzadeh","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2025.107012_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108171","article-title":"Enhancing autophagy in Alzheimer's disease through drug repositioning","volume":"237","author":"Eshraghi","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.nbd.2025.107012_bb0080","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1074\/mcp.M113.035600","article-title":"Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics","volume":"13","author":"Fagerberg","year":"2014","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.nbd.2025.107012_bb0085","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/gbb.12133","article-title":"Abnormal vibrissa-related behavior and loss of barrel field inhibitory neurons in 5xFAD transgenics","volume":"13","author":"Flanigan","year":"2014","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.nbd.2025.107012_bb0090","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41597-021-01054-y","article-title":"Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer's disease","volume":"8","author":"Forner","year":"2021","journal-title":"Sci Data."},{"key":"10.1016\/j.nbd.2025.107012_bb0095","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1038\/s41593-024-01774-5","article-title":"Integrated multimodal cell atlas of Alzheimer\u2019s disease","volume":"27","author":"Gabitto","year":"2024","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2025.107012_bb0100","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s42003-019-0599-8","article-title":"3D mapping reveals network-specific amyloid progression and subcortical susceptibility in mice","volume":"2","author":"Gail Canter","year":"2019","journal-title":"Commun Biol."},{"key":"10.1016\/j.nbd.2025.107012_bb0105","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/jnc.15202","article-title":"The N-glycan profile in cortex and hippocampus is altered in Alzheimer disease","volume":"159","author":"Gaunitz","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2025.107012_bb0110","doi-asserted-by":"crossref","first-page":"7918","DOI":"10.1038\/s41467-024-52297-3","article-title":"Entorhinal cortex vulnerability to human APP expression promotes hyperexcitability and tau pathology","volume":"15","author":"Goettemoeller","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2025.107012_bb0115","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2025.107012_bb0120","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1038\/s41380-019-0483-4","article-title":"Early restoration of parvalbumin interneuron activity prevents memory loss and network hyperexcitability in a mouse model of Alzheimer's disease","volume":"25","author":"Hijazi","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.nbd.2025.107012_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209228","article-title":"Early alterations in hippocampal perisomatic GABAergic synapses and network oscillations in a mouse model of Alzheimer\u2019s disease amyloidosis","volume":"14","author":"Hollnagel","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2025.107012_bb0130","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.aad8373","article-title":"Complement and microglia mediate early synapse loss in Alzheimer mouse models","volume":"352","author":"Hong","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.nbd.2025.107012_bb0135","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.celrep.2019.08.104","article-title":"Tau-mediated disruption of the spliceosome triggers cryptic RNA splicing and neurodegeneration in Alzheimer\u2019s disease","volume":"29","author":"Hsieh","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2025.107012_bb0140","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.cell.2012.02.040","article-title":"Alzheimer mechanisms and therapeutic strategies","volume":"148","author":"Huang","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2025.107012_bb0145","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fnins.2019.00028","article-title":"\u03b1-Synuclein: a multifunctional player in exocytosis, endocytosis, and vesicle recycling","volume":"13","author":"Huang","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.nbd.2025.107012_bb0150","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3233\/JAD-2010-1203","article-title":"Altered distribution of RhoA in Alzheimer's disease and AbetaPP overexpressing mice","volume":"19","author":"Huesa","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2025.107012_bb0155","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nature20587","article-title":"Gamma frequency entrainment attenuates amyloid load and modifies microglia","volume":"540","author":"Iaccarino","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2025.107012_bb0160","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13195-025-01705-x","article-title":"Integrative network analysis reveals novel moderators of a\u03b2-tau interaction in Alzheimer's disease","volume":"17","author":"Kitani","year":"2025","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.nbd.2025.107012_bb0165","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1016\/j.bbagen.2017.04.012","article-title":"N-glycan and Alzheimer's disease","volume":"1861","author":"Kizuka","year":"2017","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.nbd.2025.107012_bb0170","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00401-006-0068-6","article-title":"Early involvement of small inhibitory cortical interneurons in Alzheimer\u2019s disease","volume":"112","author":"Koliatsos","year":"2006","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2025.107012_bb0175","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1038\/cdd.2014.67","article-title":"Crucial role of calbindin-D28k in the pathogenesis of Alzheimer\u2019s disease mouse model","volume":"21","author":"Kook","year":"2014","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.nbd.2025.107012_bb0180","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1038\/s41467-024-47028-7","article-title":"Native-state proteomics of Parvalbumin interneurons identifies unique molecular signatures and vulnerabilities to early Alzheimer's pathology","volume":"15","author":"Kumar","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2025.107012_bb0185","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1016\/j.neuron.2024.05.017","article-title":"Navigating through the complexities of synucleinopathies: insights into pathogenesis, heterogeneity, and future perspectives","volume":"112","author":"L\u00e1zaro","year":"2024","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2025.107012_bb0190","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1523\/JNEUROSCI.2983-18.2018","article-title":"Pyk2 signaling through Graf1 and RhoA GTPase is required for amyloid-\u03b2 oligomer-triggered synapse loss","volume":"39","author":"Lee","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.107012_bb0195","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41593-022-01084-8","article-title":"Faulty autolysosome acidification in Alzheimer\u2019s disease mouse models induces autophagic build-up of a\u03b2 in neurons, yielding senile plaques","volume":"25","author":"Lee","year":"2022","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2025.107012_bb0200","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41593-020-00764-7","article-title":"Molecular characterization of selectively vulnerable neurons in Alzheimer's disease","volume":"24","author":"Leng","year":"2021","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2025.107012_bb0205","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nrn1519","article-title":"Interneurons of the neocortical inhibitory system","volume":"5","author":"Markram","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2025.107012_bb0210","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.neuron.2018.02.029","article-title":"Nav1.1-overexpressing interneuron transplants restore brain rhythms and cognition in a mouse model of Alzheimer's disease","volume":"98","author":"Martinez-Losa","year":"2018","journal-title":"Neuron"},{"issue":"256\u2013271","key":"10.1016\/j.nbd.2025.107012_bb0215","article-title":"Multi-sensory gamma stimulation ameliorates Alzheimer\u2019s-associated pathology and improves cognition","volume":"177","author":"Martorell","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2025.107012_bb0220","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41380-022-01631-6","article-title":"Mitophagy in Alzheimer's disease: molecular defects and therapeutic approaches","volume":"28","author":"Mary","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.nbd.2025.107012_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053349","article-title":"Reduced RAN expression and disrupted transport between cytoplasm and nucleus; a key event in Alzheimer's disease pathophysiology","volume":"8","author":"Mastroeni","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2025.107012_bb0230","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/s41586-024-07606-7","article-title":"Single-cell multiregion dissection of Alzheimer's disease","volume":"632","author":"Mathys","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2025.107012_bb0235","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41587-020-0472-9","article-title":"Multiplex digital spatial profiling of proteins and RNA in fixed tissue","author":"Merritt","year":"2020","journal-title":"Nat Biotechnol, United States"},{"key":"10.1016\/j.nbd.2025.107012_bb0240","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3389\/fnagi.2017.00345","article-title":"Insulin resistance and Alzheimer\u2019s disease: bioenergetic linkages","volume":"9","author":"Neth","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.nbd.2025.107012_bb0245","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1021\/acs.jproteome.6b00925","article-title":"A shotgun proteomics approach reveals a new toxic role for Alzheimer's disease a\u03b2 peptide: spliceosome impairment","volume":"16","author":"Nuzzo","year":"2017","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.nbd.2025.107012_bb0250","series-title":"GeomxTools: NanoString GeoMx Tools. R Package Version 1.0. 0","author":"Ortogero","year":"2021"},{"key":"10.1016\/j.nbd.2025.107012_bb0255","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nrn.2016.141","article-title":"Network abnormalities and interneuron dysfunction in Alzheimer disease","volume":"17","author":"Palop","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2025.107012_bb0260","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nature05289","article-title":"A network dysfunction perspective on neurodegenerative diseases","volume":"443","author":"Palop","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2025.107012_bb0265","doi-asserted-by":"crossref","first-page":"13322","DOI":"10.1038\/s41598-020-70153-4","article-title":"Signaling via the p75 neurotrophin receptor facilitates amyloid-\u03b2-induced dendritic spine pathology","volume":"10","author":"Patnaik","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2025.107012_bb0270","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0306-4522(93)90331-9","article-title":"Cultured GABA-immunoreactive neurons are resistant to toxicity induced by beta-amyloid","volume":"56","author":"Pike","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2025.107012_bb0275","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1089\/brain.2020.0879","article-title":"Understanding changes in hippocampal interneurons subtypes in the pathogenesis of Alzheimer\u2019s disease: a systematic review","volume":"11","author":"Reid","year":"2021","journal-title":"Brain Connect."},{"key":"10.1016\/j.nbd.2025.107012_bb0280","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/brain\/105.2.313","article-title":"A post-mortem study of the cholinergic and GABA systems in senile dementia","volume":"105","author":"Rossor","year":"1982","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2025.107012_bb0285","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1007\/s12031-020-01667-9","article-title":"CHI3L2 expression levels are correlated with AIF1, PECAM1, and CALB1 in the brains of Alzheimer's disease patients","volume":"70","author":"Sanfilippo","year":"2020","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.nbd.2025.107012_bb0290","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1021\/cb400080f","article-title":"Untangling amyloid-\u03b2, tau, and metals in Alzheimer\u2019s disease","volume":"8","author":"Savelieff","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.nbd.2025.107012_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2022.108333","article-title":"Diabetes and dementia: clinical perspective, innovation, knowledge gaps","volume":"36","author":"Savelieff","year":"2022","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.nbd.2025.107012_bb0300","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2025.107012_bb0305","doi-asserted-by":"crossref","DOI":"10.3390\/cells11091520","article-title":"RhoA signaling in neurodegenerative diseases","volume":"11","author":"Schmidt","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.nbd.2025.107012_bb0310","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1074\/jbc.M115.695916","article-title":"Deficiency of neuronal p38\u03b1 MAPK attenuates amyloid pathology in Alzheimer disease mouse and cell models through facilitating lysosomal degradation of BACE1","volume":"291","author":"Schn\u00f6der","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2025.107012_bb0315","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1474-4422(20)30412-9","article-title":"APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches","volume":"20","author":"Serrano-Pozo","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2025.107012_bb0320","article-title":"Alzheimer's disease beyond amyloid: strategies for future therapeutic interventions","volume":"371","author":"Shi","year":"2020","journal-title":"Bmj"},{"key":"10.1016\/j.nbd.2025.107012_bb0325","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41386-022-01435-w","article-title":"Prefrontal parvalbumin interneurons deficits mediate early emotional dysfunction in Alzheimer's disease","volume":"48","author":"Shu","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nbd.2025.107012_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2022.100433","article-title":"Glycoproteomics landscape of asymptomatic and symptomatic human Alzheimer's disease brain","volume":"21","author":"Suttapitugsakul","year":"2022","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.nbd.2025.107012_bb0335","doi-asserted-by":"crossref","first-page":"7816","DOI":"10.1038\/s41598-023-34787-4","article-title":"Transcriptomic and glycomic analyses highlight pathway-specific glycosylation alterations unique to Alzheimer's disease","volume":"13","author":"Tang","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2025.107012_bb0340","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","article-title":"Phases of a beta-deposition in the human brain and its relevance for the development of AD","volume":"58","author":"Thal","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2025.107012_bb0345","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13024-019-0320-x","article-title":"\u03b1-Synuclein in the pathophysiology of Alzheimer\u2019s disease","volume":"14","author":"Twohig","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2025.107012_bb0350","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23063223","article-title":"Oncogenic pathways in neurodegenerative diseases","volume":"23","author":"Varela","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2025.107012_bb0355","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.cell.2012.02.046","article-title":"Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model","volume":"149","author":"Verret","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2025.107012_bb0360","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1001\/jamaneurol.2013.136","article-title":"Seizures and epileptiform activity in the early stages of Alzheimer disease","volume":"70","author":"Vossel","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nbd.2025.107012_bb0365","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/ana.24794","article-title":"Incidence and impact of subclinical epileptiform activity in Alzheimer\u2019s disease","volume":"80","author":"Vossel","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2025.107012_bb0370","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13024-020-00376-6","article-title":"Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances","volume":"15","author":"Wang","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2025.107012_bb0375","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3389\/fnins.2020.00660","article-title":"GABAergic inhibitory interneuron deficits in Alzheimer's disease: implications for treatment","volume":"14","author":"Xu","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.nbd.2025.107012_bb0380","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1001\/jamapsychiatry.2020.1807","article-title":"Cortical proteins associated with cognitive resilience in community-dwelling older persons","volume":"77","author":"Yu","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.nbd.2025.107012_bb0385","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41593-022-01251-x","article-title":"Integrative in situ mapping of single-cell transcriptional states and tissue histopathology in a mouse model of Alzheimer's disease","volume":"26","author":"Zeng","year":"2023","journal-title":"Nat. Neurosci."},{"issue":"331\u2013345","key":"10.1016\/j.nbd.2025.107012_bb0390","article-title":"Interneuron accumulation of phosphorylated tau impairs adult hippocampal neurogenesis by suppressing GABAergic transmission","volume":"26","author":"Zheng","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.nbd.2025.107012_bb0395","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/ana.24361","article-title":"Inhibition of c-Jun N-terminal kinase activation reverses Alzheimer disease phenotypes in APPswe\/PS1dE9 mice","volume":"77","author":"Zhou","year":"2015","journal-title":"Ann. Neurol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125002281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125002281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:36:00Z","timestamp":1782488160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996125002281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":79,"alternative-id":["S0969996125002281"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2025.107012","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.11.01.565165","asserted-by":"object"}]},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interneuron transcriptomics reveals pathologic markers of Alzheimer's disease progression","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2025.107012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107012"}}